# FDA UNTITLED_LETTER - Novartis Pharmaceuticals Corporation - August 08, 2023

Source: https://www.globalkeysolutions.net/records/untitled_letter/novartis-pharmaceuticals-corporation/cd26624a-3912-48a5-979f-444b80110332

> FDA UNTITLED_LETTER for Novartis Pharmaceuticals Corporation on August 08, 2023. Product: N/A. Access full analysis and detailed observations.

---

## Details

- Record Type: UNTITLED_LETTER
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2023-08-08

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/novartis-pharmaceuticals-corporation/3ffb1966-8e60-47ad-abf0-459802dcfdb9)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/novartis-pharmaceuticals-corporation/1e78a74f-5ad0-418f-9e80-40cb8ef2780e)

## Related Officers

- [Director of Compliance Branch](https://www.globalkeysolutions.net/people/alexander-lopez/0226b709-12ab-42a4-b63b-c7e8ce64ea02)

Company: https://www.globalkeysolutions.net/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47